Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

14 Jan 2022 07:01

RNS Number : 4163Y
Osirium Technologies PLC
14 January 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

14 January 2022

 

Osirium Technolgies plc

("Osirium" or the "Group")

 

Trading Update

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity software, today provides an update on the trading for the financial year ended 31 December 2021 ahead of its audited final results.

 

Trading update

 

Further to the Company's announcement on 29 November 2021, the Board confirms that, subject to completion of the audit, it expects to report bookings and revenue for the 12 months to 31 December 2021 of at least £1.6 million (2020: £1.57 million) and £1.45 million (2020: £1.43 million) respectively, in line with the prior year. Deferred revenue at 31 December 2021 was £1.66 million, providing visibility as the Group starts the new year. Debtors and cash balances as at 31 December 2021 were £0.7 million.

 

Osirium has more than doubled its customer base in 2021 to over 100 customers at 31 December 2021. New customers signed in Q4 2021 included two more NHS trusts, an international telecoms operator and a London-based law firm. Customer retention rates for the year were 95.4% by value (2020: 98.5% retention rate).

 

The Group sold through 28 resellers in 2021, and Osirium's increasing emphasis on its reseller and distributor model means it achieved a number of sales in new territories across Western Europe, Central and Eastern Europe, and South Africa.

 

Whilst average initial contract values have been lower due to the delayed decision making on larger strategic IT projects throughout the pandemic, the Group's significantly increased customer base provides increased up-sell opportunities, in line with its land and expand strategy. The Group expects to build on existing contracts and expand its services with its new customers in 2022 alongside accelerating new customer acquisition. Osirium starts the new year with c. £1.5 million of anticipated bookings from existing customer renewals due in 2022, which, coupled with the Company's track record of high customer retention, provides a strong foundation for the Group to execute its growth strategy.

 

 

David Guyatt, CEO of Osirium, commented:

 

"We are pleased with the strong growth in customer numbers and high customer retention rates during 2021, which is testament to the need for our offering across a range of sectors and geographies despite the effects of the pandemic upon customer decision making. We expect this customer decision making to return towards normal levels in 2022.

 

"With a significantly broadened customer base, our teams have the opportunity to focus on upselling and cross-selling in line with our land-and-expand strategy. We have made good progress in the year following a focus on growing our partner network which is yielding results, and we continue to assess the Company's go-to-market strategies to ensure the Group remains well-positioned to capture the substantial market opportunity available. I look forward to providing a full update to shareholders at the final results later in the year."

 

Contacts:

 

 

 

Osirium Technologies plc

Tel: +44 (0)1183 242 444

David Guyatt, CEO

 

Rupert Hutton, CFO

 

 

 

Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve/George Payne (Corporate Finance)

 

Tony Quirke (Sales and Corporate Broking)

 

 

 

Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny

 

Faye Calow

 

 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain. 

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFXLLFLFLBBBL
Date   Source Headline
31st Oct 20237:00 amRNSCancellation - Osirium Technologies plc
30th Oct 202310:39 amRNSSCHEME OF ARRANGEMENT BECOMES EFFECTIVE
30th Oct 20237:30 amRNSSuspension - Osirium Technologies plc
26th Oct 202311:22 amRNSCourt Sanction of Scheme of Arrangement
12th Oct 20233:09 pmRNSResults of Court Meeting and General Meeting
28th Sep 20234:33 pmRNSForm 8.3 - Osirium Technologies plc
27th Sep 20231:36 pmRNSForm 8.3 - Osirium Technologies plc
18th Sep 20237:00 amRNSPublication and Posting of Scheme Document
14th Sep 20231:34 pmRNSForm 8.3 - Osirium Technologies PLC
8th Sep 20232:08 pmRNSForm 8.3 - Osirium Technologies plc
7th Sep 20234:09 pmRNSForm 8.3 - Osirium Technologies plc
7th Sep 20237:00 amRNSInterim Results
5th Sep 20233:14 pmGNWCorrection: Form 8.3 - Octopus Investments - Osirium Technologies plc
5th Sep 20237:00 amRNSForm 8 (OPD) Osirium Technologies plc
1st Sep 20234:58 pmRNSForm 8.3 - Osirium Technologies plc
1st Sep 202311:10 amRNSForm 8.3 - Osirium Technologies plc- Amendment
31st Aug 20234:24 pmRNSForm 8.3 - Osirium Technologies PLC
31st Aug 20232:02 pmGNWForm 8.3 - Osirium Technologies plc
31st Aug 202311:28 amRNSForm 8.3 - Osirium Technologies plc
31st Aug 202310:51 amRNSForm 8.3 - Osirium Technologies plc
31st Aug 20239:50 amRNSForm 8 (DD) - Osirium Technologies plc
30th Aug 202312:00 pmRNSRecommended Acquisition of Osirium Technologies
18th Jul 20237:00 amRNSHalf Year Trading Update
13th Jun 20237:00 amRNSAttendance at InfoSec Europe 2023
22nd May 20237:00 amRNSGrant of Options and PDMR Dealings
9th May 202312:40 pmRNSResult of AGM
9th May 20237:00 amRNSAGM Statement and Q1 trading update
18th Apr 20237:00 amRNSUpdate re proposed grant of options
3rd Apr 20237:00 amRNSNotice of AGM & Proposed Changes to Option Scheme
24th Mar 20234:40 pmRNSSecond Price Monitoring Extn
24th Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Mar 20237:00 amRNSFinal Results
10th Jan 20232:05 pmRNSSecond Price Monitoring Extn
10th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 20239:00 amRNSPrice Monitoring Extension
9th Jan 20237:00 amRNSFull Year Trading Update
4th Jan 202311:59 amRNSHolding(s) in Company
3rd Jan 20237:00 amRNSConfirmation of Board Changes
30th Dec 20227:00 amRNSTotal Voting Rights
19th Dec 202210:30 amRNSHoldings in Company
15th Dec 202211:51 amRNSHolding(s) in Company
15th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20222:25 pmRNSHolding(s) in Company
12th Dec 202210:19 amRNSResult of General Meeting
30th Nov 20227:00 amRNSTotal Voting Rights
28th Nov 20223:12 pmRNSTR-1: Notification of Major Holdings
28th Nov 20223:11 pmRNSTR-1: Notification of Major Holdings
28th Nov 20223:10 pmRNSTR-1: Notification of Major Holdings
22nd Nov 20227:00 amRNSProposed Placing, Subscription, Board Changes & GM
1st Nov 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.